A randomized clinical trial of the efficacy of extended smoking cessation treatment for adolescent smokers

Steffani R Bailey, Sarah A Hagen, Christina J Jeffery, Christopher T Harrison, Seth Ammerman, Susan W Bryson, Diana T Killen, Thomas N Robinson, Joel D Killen, Steffani R Bailey, Sarah A Hagen, Christina J Jeffery, Christopher T Harrison, Seth Ammerman, Susan W Bryson, Diana T Killen, Thomas N Robinson, Joel D Killen

Abstract

Introduction: Relatively few well-designed smoking cessation studies have been conducted with teen smokers. This study examined the efficacy of extended cognitive-behavioral treatment in promoting longer term smoking cessation among adolescents.

Methods: Open-label smoking cessation treatment consisted of 10 weeks of school-based, cognitive-behavioral group counseling along with 9 weeks of nicotine replacement (nicotine patch). A total of 141 adolescent smokers in continuation high schools in the San Francisco Bay Area were randomized to either 9 additional group sessions over a 14-week period (extended group) or 4 monthly smoking status calls (nonextended group). Intention-to-treat logistic regression analysis was used to assess the primary outcome of biologically confirmed (carbon monoxide < 9 ppm) point prevalence abstinence at Week 26 (6-month follow-up from baseline).

Results: At Week 26 follow-up, the extended treatment group had a significantly higher abstinence rate (21%) than the nonextended treatment (7%; OR = 4.24, 95% CI: 1.20-15.02). Females also were more likely to be abstinent at the follow-up than males (OR = 4.15, 95% CI: 1.17-14.71).

Conclusions: The significantly higher abstinence rate at follow-up for the extended treatment group provides strong support for continued development of longer term interventions for adolescent smoking cessation.

Figures

Figure 1.
Figure 1.
Flowchart of attrition of adolescent smokers over 26 weeks.

Source: PubMed

3
订阅